CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Therapeutic Areas
🎗️

Oncology

236 drugs in pipeline from 10 companies

236

Drugs in Pipeline

10

Companies

10

Upcoming Catalysts

236

Phase 3 Trials

Upcoming Catalysts
Today
LSTAPhase 2

certepetide Phase 2 Results Expected

certepetide67
Apr 18
CT.gov
00%
2d
days
MRKPhase 2
✓Positive

favezelimab/pembrolizumab Phase 2 Results Expected

favezelimab/pembrolizumab315
Apr 20
CT.gov
2d
days
MRKPhase 2

lenvatinib Phase 2 Results Expected

Lenvatinib315
Apr 20
CT.gov
00%
2d
days
MRKPhase 2

Vibostolimab Phase 2 Results Expected

Vibostolimab315
Apr 20
CT.gov
00%
2d
days
MRKPhase 2

ATRA Phase 2 Results Expected

ATRA315
Apr 20
CT.gov
00%
2d
days
MRKPhase 2

Pembrolizumab/Quavonlimab Phase 2 Results Expected

Pembrolizumab/Quavonlimab315
Apr 20
CT.gov
00%
2d
days
MRKPhase 2

pembrolizumab Phase 2 Results Expected

pembrolizumab315
Apr 20
CT.gov
00%
4d
MRKPhase 2

Zilovertamab vedotin Phase 2 Results Expected

MK-2140 (zilovertamab vedotin)140
Apr 22
CT.gov
00%
2w
PFEPhase 3
✗Negative

Elranatamab Phase 3 Results Expected

Elranatamab944
Apr 27
CT.gov
2w
PFEPhase 3
✓Positive

Daratumumab Phase 3 Results Expected

Daratumumab944
Apr 27
CT.gov
View all catalysts
Pipeline by Phase
Phase 3
236
Active Companies
MRK

MERCK

24 drugs
GILD

Gilead Sciences, Inc.

2 drugs
PFE

PFIZER

13 drugs
AZNCF

ASTRAZENECA PLC

20 drugs
JAZZ

Jazz Pharmaceuticals plc

1 drugs
GSK

GSK plc

4 drugs
BAYRY

BAYER

3 drugs
CELG-RI

BRISTOL MYERS SQUIBB CO

7 drugs
NVSEF

NOVARTIS AG

9 drugs
ALPMY

Astellas Pharma

2 drugs
Related Conditions
cancertumorcarcinomalymphomaleukemiamelanomaoncologysarcomamyelomametastaticneoplasmmalignantbreast cancerlung cancerprostate cancercolorectalpancreaticglioblastomahepatocellularrenal cellovarianbladdernsclcsclcamlcllalldlbclhodgkinnon-hodgkin